The Weekly Roundup: April 7-11
Dermatology Times
APRIL 12, 2025
In case you missed it, this week we had news about Alphyn Biologics' first patient dosed with zabalafin hydrogel, abrocitinib for Netherton Syndrome, the ICONIC-LEAD phase 3 study, and more.
Let's personalize your content